Jump to content

1P-AL-LAD

From Wikipedia, the free encyclopedia
1P-AL-LAD
Identifiers
  • (6aR,9R)-N,N-diethyl-4-propanoyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChem CID
Chemical and physical data
FormulaC25H31N3O2
Molar mass405.542 g·mol−1
3D model (JSmol)
  • CCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3CC=C)C(=O)N(CC)CC)C4=C2C1=CC=C4
  • InChI=1S/C25H31N3O2/c1-5-12-27-15-18(25(30)26(7-3)8-4)13-20-19-10-9-11-21-24(19)17(14-22(20)27)16-28(21)23(29)6-2/h5,9-11,13,16,18,22H,1,6-8,12,14-15H2,2-4H3/t18-,22-/m1/s1
  • Key:GAGOTJNMWJYWMB-XMSQKQJNSA-N

1P-AL-LAD is a derivative of lysergic acid diethylamide (LSD) which has psychedelic effects and has been sold as a designer drug. It is believed to act as a prodrug for AL-LAD and produces a head-twitch response in animal studies.[1]

See also

[edit]

References

[edit]
  1. ^ Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL (August 2022). "Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD". Drug Testing and Analysis. 14 (8): 1503–1518. doi:10.1002/dta.3281. PMC 9546273. PMID 35524430.